In a different study, we analyzed the glycome of drug-resistant ICN13 BCP-ALL cells and found that these cells exhibit reduced overall sialylation, with a shift from α2-6- to α2-3-linked Sia without significant changes in expression of ST6GAL1 (Oliveira et al., in preparation). The gene discussed is ST6GAL1; the disease is acute lymphoblastic leukemia.